Donations Contact Us Home Page
The DreamThe CenterThe FoundationThe StaffIn The NewsLinks

From research to treatment, Elliott, Elliott, Head Center at forefront
of breast care

Most Baton Rouge residents don’t know it, but one of the most renowned breast cancer centers in the world is located right here, at the Summit Hospital campus off O’Neal Lane. Some of its latest research offers not only hope for women with breast cancer, but also great news for men with prostate cancer.

Led by Dr. Robert Elliott, the Elliott, Elliott, Head Breast Cancer Research & Treatment Center is extraordinary for two reasons. First, it is one of very few clinics to offer comprehensive care in one center. EEHC provides early detection through on-site mammography, ultrasound, infrared imaging and education, along with treatment of breast disease on its spacious fourth floor suite at Physicians Plaza II. Second, it is rare to find a breast center that also has a certified laboratory and conducts ongoing breast cancer research to improve survival rates and provide the least invasive treatments.

Having conducted research for the last 20 years, EEHC has developed and patented an innovative vaccine treatment to boost a patient’s immunity to her own cancer. This treatment is used in conjunction with other treatments, such as chemotherapy, to improve a patent’s chances for long-term survival. "This provides some hope for women who have had conventional therapy that has proven ineffective," Dr. Elliott said.

The exciting news coming from the research center now is related to men. A vaccine with PSA antigen has been developed to eliminate prostate cancer in men. "We have had very exciting results in the first trial study of 10 men with prostate cancer," said Dr. Elliott. "We have reduced their PSA levels to the normal range and obliterated tumors in a significant number of the men without any other treatment." While more research is needed, if this vaccine is proven to be effective, it could eliminate surgery and other prostate cancer treatments that have severe side effects.

Other research in the EEHC laboratory has resulted in these advances:

  • The use of tumor markers, which are a very early detection system for finding recurrences in breast cancer through changes in blood proteins
  • Transferrin-based chemotherapy, which takes advantage of the high uptake of iron by tumor cells. This treatment involves attaching cancer-killing drugs to the iron carrier transferrin.

Only a man of great passion for his work would follow the road of Dr. Elliott. He has spent hundreds of thousands of dollars on the latest equipment for diagnosis, treatment and research, and dedicated hundreds of thousands of hours to the study of breast cancer. His director of research, Dr. Jonathan Head, is a Ph.D. tumor biologist. Dr. Head has been instrumental in many of the advances made in the 4,000-square-foot research laboratory at EEHC.

Also working with Dr. Head are a cell biologist and a molecular biologist. Much of their research has been funded by Dr. Elliott in his quest to eradicate breast cancer.

The center has published many research papers in medical journals and presented its findings at many medical conferences across the world. Dr. Elliott and his staff have also conducted medical training for other physicians and medical technicians.

But Dr. Elliott has not limited his work to research. He has also had a passion for providing the least invasive treatments for women.

Dr. Elliott was one of the first physicians in the country to perform stereotactic needle biopsy, which is a procedure requiring only a local anesthetic and minimally invasive surgery to perform a breast biopsy, rather than general anesthesia and more invasive open surgical biopsy.

This procedure led to the development of radiofrequency ablation, which eliminates tumors of one centimeter or less via a radiofrequency probe. Not only does it eliminate tumors at a very early stage, it also eliminates the need for more invasive surgery.

Summit Hospital joined forces with Dr. Elliott to provide another procedure, one which determines whether cancer has spread to lymph nodes, but does so without removing all the nodes. Called sentinel node biopsy, this procedure involves the injection of a radioactive isotope and a dye, which maps out the first node, draining the tumor basin. Then the sentinel node is thoroughly examined for the presence of cancer cells. Summit purchased $25,000 of specialized equipment and provided special training for its surgical nurses to assist Dr. Elliott in performing the procedure.

"We are state-of-the-art in early detection, diagnosis and treatment," said Dr. Elliott. "Women come here from across the country for treatment. When we do a mammogram, women know before they leave what the results are. If there is a problem, they know it on that visit, not two or three weeks later."

Both Dr. Elliott and Dr. Head promote use of the least invasive treatment possible for breast cancer. "This clinic is unique in that the same people who do the mammogram also read it, provide patient care and perform many of the procedures, so there isn’t that fractionalized care. One result of fractionalized care can be overtreatment of a patient. That is less likely here," said Dr. Head. "There are less than a handful of centers like this across the country."

Dr. Elliott performs his surgical procedures at Summit Hospital. "We perform a number of procedures in our breast center, but we go next door to Summit for procedures such as the sentinel node biopsies and open biopsies, mastectomies, duct excisions, CT and bone scans, and nuclear medicine," Dr. Elliott said. "Summit has been very accommodating, and we have been pleased with the high level of patient care."

EEHC is also unlike other breast cancer clinics in that it offers a chemotherapy suite, bone density screening, radiology and infrared imaging on site. A certified oncology nurse and an anesthesiologist who specializes in pain management are also on staff. Dr. Mary Elliott, wife of Dr. Elliott, specializes in primary breast health care, teaches self examinations and monitors chemotherapy patients. A chemist and physician, she produces the center’s biological response modifier drug, which has provided dramatic results for some critically ill patients. EEHC provides patients not only with the latest in technology, but also with a staff of competent, skilled, caring professionals committed to their care.

Located at 17050 Medical Center Drive on the Summit Hospital campus, EEHC is an international leader in women’s breast care and cancer treatment—right here in Baton Rouge.

<...back>